Skip to content
User

Viking Global Investors DMRA trades

Ole Andreas Halvorsen

Ole Andreas Halvorsen Damora Therapeutics, Inc stake

total: 682

Trades details

Total transactions:
2
New positions:
1
Reduced:
1
Held for:
0 quarters
Latest activity:
2026 Q3
According to 2026 Q3 report, Ole Andreas Halvorsen holds 1,207,985 Damora Therapeutics, Inc (DMRA) shares with a market value of roughly $25.71M accounting for 0.08% of the overall portfolio. Viking Global Investors first purchased DMRA in 2026 Q1, initially acquiring about 2.31M shares. Since the initial investment in Damora Therapeutics, Inc (DMRA), Viking Global Investors has made 1 more transaction.

How many DMRA shares does Ole Andreas Halvorsen currently hold?

According to 2026 Q3 report, Ole Andreas Halvorsen holds 1,207,985 shares of Damora Therapeutics, Inc (DMRA), valued at around $25.71M.

When did Ole Andreas Halvorsen buy Damora Therapeutics, Inc (DMRA)?

Ole Andreas Halvorsen first invested in Damora Therapeutics, Inc (DMRA) in 2026 Q1 at the reported quarter-end price of $25.90 per share.

Ole Andreas Halvorsen's historical trades in Damora Therapeutics, Inc

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
0.08%
1,207,985
$21.28
$25,705,921
-47.73% (-1,103,097)
-0.07%
2026 Q1
0.17%
2,311,082
$25.90
$59,857,024
new
+0.17%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.